How often have you been told to eat more protein and less carbohydrates to stay healthy? This is not an emerging food culture but rather a prevailing dogma in o
Archivi categoria: letteratura
High-protein diet is bad for kidney health: unleashing the taboo | Nephrology Dialysis Transplantation | Oxford Academic
Suicide rates are defined as the number of deaths deliberately initiated and performed by a person in the full knowledge or expectation of its fatal outcome.
### What you need to know Hypertension is a leading global cause of morbidity and mortality. More than 25% of the adult UK population has hypertension, and in about 30% blood pressure remains uncontrolled.1 In August, the National Institute for Health and Care Excellence (NICE) published its updated guideline on the diagnosis and management of hypertension. The guideline reviews further evidence that has emerged since it was last updated in 2011 from randomised trials investigating the initiation, monitoring, and choice of antihypertensive treatment. The scope of the updated guideline has increased to also include people with type 2 diabetes, but does not make recommendations for people with chronic kidney disease, established cardiovascular disease, or hypertension in pregnancy. This article summarises the most recent recommendations from NICE and includes information considered to be most relevant to primary care clinicians. Key changes to current practice include offering drug treatment to people at a lower threshold for 10 year risk of cardiovascular disease, emphasis on maintaining blood pressure below target, and clarifying criteria for same day specialist review in people
Gianna MilanoNegli anni la soglia di sicurezza nel sangue per il colesterolo è stata via via abbassata da linee guida (tutt’altro che limpide), ampliando a dismisura il bacino dei candidati al consumo delle statine.
Chronic Kidney Disease Diagnosis and Management: A Review | Chronic Kidney Disease | JAMA | JAMA Network
This narrative review discusses the diagnosis, evaluation, staging, and management of chronic kidney disease (CKD), including discussion of new calculators for determining risk of CKD progression, treatment of complications, and considerations for referral to a nephrologist and dialysis initiation.
Dysproteinemic kidney diseases occur when B- or plasma cell clones produce pathogenic monoclonal immunoglobulins or light chains that cause kidney dam…
The Use of Erythropoiesis-Stimulating Agents in Patients With CKD and Cancer: A Clinical Approach – American Journal of Kidney Diseases
Erythropoiesis-stimulating agents (ESAs) have been used to manage anemia in chronic kidney disease (CKD) to reduce transfusion requirements and anemia symptoms. Lack of objective benefit of normalizing hemoglobin (Hb) levels and increased evidence of ESA-induced complications in persons with anemia has resulted in clinicians generally attempting to maintain Hb levels in the 10- to 11-g/dL range. In 2000, concerns in patients with cancer arose attributable to associations of ESA use with increased mortality, thrombotic complications, and cerebrovascular accidents led to a change in US Food and Drug Administration oncology guidelines regarding limitation of ESA use for chemotherapy-induced anemia.